THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS

EHA Library, Erlie Jiang, 385746

OUTCOMES OF YOUNG ADULTS (AGED ≤40 YEARS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANT

EHA Library, Oren Pasvolsky, 385747

CLINICAL CHARACTERISTICS AND OUTCOMES OF ALLOGENEIC  STEM CELL TRANSPLANTATION RECIPIENTS WITH CORONAVIRUS DISEASE 2019 CAUSED BY THE OMICRON VARIANT: A PROSPECTIVE, OBSERVATIONAL COHORT STUDY

EHA Library, Shuang Fan, 385748

HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AS THE FIRST-LINE THERAPY OF FOLLICULAR LYMPHOMA: RESULTS FROM A PROSPECTIVE SINGLE-CENTER STUDY.

EHA Library, Anna Smolyaninova, 385749

SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ALSO THE CURATIVE AND SAFE TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN THE ERA OF TARGETED THERAPY

EHA Library, 占祥 刘, 385750

DARATUMUMAB-BASED MAINTENANCE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AFTER SALVAGE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Oren Pasvolsky, 385751

TREATMENT WITH COMBINATION OF RITUXIMAB AND INTRAVENOUS Γ GLOBULIN IS EFFECTIVE IN PROMOTING ENGRAFTMENT IN DONOR SPECIFIC ANTIBODY POSITIVE PATIENTS RECEIVING HAPLOIDENTICAL STEM CELL TRANSPLANT

EHA Library, Erlie Jiang, 385752

NEPA VERSUS ONDANSETRON FOR THE PREVENTION OF CINV IN PATIENTS WITH MULTIPLE MYELOMA OR LYMPHOMA UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION. A MONOCENTRIC REAL-LIFE EXPERIENCE.

EHA Library, Idanna Innocenti, 385753

IMPACT OF HLA DISPARITY ON THE RISK OF OVERALL MORTALITY IN PATIENTS WITH EXTENSIVE CHRONIC GVHD

EHA Library, Shigeo Fuji, 385754

PREDICTING SHORT-TERM AND LONG-TERM MORTALITIES FROM SEPSIS IN PATIENTS WHO RECEIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Ye-Jun Wu, 385755

RUXOLITINIB AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA PATIENTS

EHA Library, Erlie Jiang, 385756

THE DIRECT HEALTHCARE BURDEN ASSOCIATED WITH CHRONIC GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT IN ENGLAND: A REAL-WORLD EVIDENCE ANALYSIS

EHA Library, Daniele Avenoso, 385757

HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEPATITIS‑ASSOCIATED APLASTIC ANEMIA AND NON‑HEPATITIS‑ASSOCIATED APLASTIC ANEMIA: A PROPENSITY SCORE-MATCHED ANALYSIS

EHA Library, Jia Li, 385758

LONG-TERM SAFETY AND EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS AS EARLY SECOND-LINE TREATMENT FOR PATIENTS WITH STEROID-DEPENDENT OR REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE.

EHA Library, Eleni Papchianou, 385759

CHARACTERISTICS OF MEMBRANOUS NEPHROPATHY AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yue Jin, 385760

LOW DOSE RITUXIMAB FOR PRE-EMPTIVE TREATMENT OF EPSTEIN BARR VIRUS REACTIVATION AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE SINGLE-CENTER STUDY

EHA Library, Chen Mei, 385761

MONITORING OF CIRCULATING CELL FREE DNA IN HEMATOPOIETIC STEM CELL DONORS

EHA Library, Tatyana Rybolovleva, 385762

THE CHRONOLOGICAL SEQUENCE OF 12 GY TOTAL BODY IRRADIATION AND CYCLOPHOSPHAMIDE CONDITIONING DOES NOT IMPACT OUTCOMES IN AML PATIENTS UNDERGOING MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Georg-Nikolaus Franke, 385763

INCREASED EFFICACY OF INTERMEDIATE-DOSE ARAC+G-CSF COMPARED TO CY+G-CSF AND PLERIXAFOR+G-CSF AS A STEM CELL MOBILIZATION REGIMEN IN POOR MOBILIZERS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Svetlana Elkhova, 385764

TIME-DEPENDENT ANALYSIS OF THE IMPACT ON EARLY CMV REACTIVATION OF HLA MISMATCH AND ACUTE GRAFT-VERSUS-HOST-DISEASE AFTER ALLO-HSCT FROM RELATED DONORS IN ACQUIRED APLASTIC ANEMIA.

EHA Library, Fan Lin, 385765

CLOSTRIDIUM BUTYRICUM MIYAIRI 588 CONTRIBUTES TO THE MAINTENANCE OF INTESTINAL MICROBIOTA DIVERSITY EARLY AFTER HEMATOPOIETIC CELL TRANSPLANTATION.

EHA Library, Kentaro Fukushima, 385766

TREATMENT WITH MIDOSTAURIN AND OTHER FLT3 TARGETING INHIBITORS IS ASSOCIATED WITH AN INCREASED RISK OF CARDIOVASCULAR ADVERSE EVENTS IN PATIENTS WITH FLT3 MUTATED AML WHO UNDERWENT ALLOGENEIC HCT

EHA Library, Anjali Cremer, 385767

PREDICTING SEVERE ACUTE GRAFT VERSUS HOST DISEASE IN ALLOGENEIC STEM CELL TRANSPLANTATION BY HIGH-THROUGHPUT SEQUENCING AFTER PRETRANSPLANT-MIXED LYMPHOCYTE REACTION

EHA Library, Jia Liu, 385768

CLINICAL ANALYSIS OF THE RELATIONSHIP BETWEEN PLASMA SC5B-9 LEVEL AND TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) IN PEDIATRIC PATIENTS

EHA Library, linlin luo, 385769

EFFECTS OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES (DSA) FOR PRIMARY GRAFT FAILURE OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA MAJOR

EHA Library, Jianyun Liao, 385770

THE PROGNOSIS AND COMPLICATIONS OF PATIENTS WITH PRE-TRANSPLANT LIVER DYSFUNCTION

EHA Library, Yukiko Misaki, 385771

EFFICACY AND SAFETY OF DOSE-ADJUSTED ATG COMBINED WITH CD25 ANTIBODY IN THE PREVENTION OF GVHD AFTER HAPLO-HSCT: CLINICAL STUDY DATA FROM A SINGLE CENTER IN CHINA

EHA Library, Lidan Zhu, 385772

EFFICACY AND SAFETY OF HEROMBOPAG FOR THE TREATMENT OF SECONDARY FAILURE OF PLATELET RECOVERY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Huanfeng Liu, 385773

HEMATOPOIETIC STEM/PROGENITOR CELLS ORIGINATING FROM EXTRAEMBRYONIC ARTERIAL VESSELS ARE THE MAJOR CONTRIBUTORS TO MOUSE FETAL LYMPHO-MYELOPOIESIS

EHA Library, Emanuele Azzoni, 385774

INHIBITING TELOMERIC DNA DAMAGE RESPONSE AS A NEW THERAPEUTIC STRATEGY TO REJUVENATE THE AGEING HEMATOPOIETIC SYSTEM

EHA Library, Alessia Oppezzo, 385775

CHRONIC INFLAMMATION PROMOTES EXTRAMEDULLARY HEMATOPOIESIS VIA UPREGULATION OF MATRIX METHALLOPROTEINASE 9

EHA Library, Maria Kuzmina, 385776

REGIONAL COMPARTMENTALIZATION OF THE BONE MARROW STROMA IS IMPORTANT FOR RESPONSES TO INFLAMMATION AND CANCER

EHA Library, James Swann, 385777

CYTOREDUCTIVE CHEMOTHERAPY COULD ACCELERATE THE LOSS OF CLONAL DIVERSITY IN HEMATOPOIETIC STEM CELLS AND PROMOTES THE CONVERGENT EVOLUTION OF THERAPY-RELATED CLONAL HEMATOPOIESIS

EHA Library, Hidetaka Uryu, 385778

DISTINCT REACTIVITY TO ENVIRONMENTAL FACTORS OF YS VERSUS HSC DERIVED PROGENITORS DICTATE HEMATOPOIESIS IN THE MOUSE FETAL LIVER

EHA Library, Francisca Soares-Da-Silva, 385779

ALL EMBRYONIC HEMATOPOIETIC WAVES EMERGE FROM HEMATO-ENDOTHELIAL PROGENITORS

EHA Library, Michaela Šímová, 385780

CHEMOTHERAPY-ACTIVATED HSCS ARE DEFINED BY HIGHLY INCREASED MITOCHONDRIAL MASS AND POTENTIAL INDEPENDENT OF CELL CYCLE STATUS

EHA Library, Els Mansell, 385781

THE IMPACT OF SMALL MOLECULE INHIBITION OF METTL3 ON NORMAL HAEMATOPOIESIS

EHA Library, Katherine Sturgess, 385782

REPAIR OF DYSFUNCTIONAL BONE MARROW ENDOTHELIAL CELLS ALLEVIATES APLASTIC ANEMIA

EHA Library, Tong Xing, 385783

LONGTERM EX VIVO EXPANSION OF FUNCTIONAL MURINE AND HUMAN HEMATOPOIETIC STEM CELLS USING BONE-LINING STROMAL CELLS

EHA Library, Lukas Klein, 385784

IDENTIFICATION OF CLONAL HEMATOPOIESIS DRIVER MUTATIONS THROUGH IN SILICO SATURATION MUTAGENESIS

EHA Library, Juan Enric Ramis-Zaldivar, 385785

VASCULARIZED BONE MARROW-ON-CHIP TO STUDY VASCULAR ABERRATION IN HEMATOPOIETIC DISEASES

EHA Library, Diana PASSARO, 385786

IMPACT OF CLONAL HEMATOPOIESIS AND CANAKINUMAB ON NON-HEMATOLOGICAL MALIGNANCY: ANALYSIS OF THE CANTOS RANDOMIZED CLINICAL TRIAL

EHA Library, Janghee Woo, 385787

MONOCYTE-DRIVEN INFLAMMATION IN DNMT3A-MUTANT CLONAL HAEMATOPOIESIS ACUTE ST-ELEVATION MYOCARDIAL INFARCTION.

EHA Library, Sarah Mackie, 385788

LC3-ASSOCIATED PHAGOCYTOSIS IS IMPAIRED IN BONE MARROW MACROPHAGES DURING AGEING LEADING TO DEFECTIVE PHAGOCYTOSIS AND ACCUMULATION OF APOPTOTIC DEBRIS WITHIN THE BONE MARROW.

EHA Library, Katherine Hampton, 385789

THE IMPACT OF CLONAL HEMATOPOIESIS ON THE RISK OF SEVERE COVID-19 INFECTION

EHA Library, Ryunosuke Saiki, 385790

TNIK SIGNALLING IMPAIRS SELF-RENEWAL AND LONG-TERM RECONSTITUTION CAPACITY OF HSCS

EHA Library, Luca Palombella, 385791

SILK BONE MARROW-LIKE TISSUE MODELS FOR PRODUCING ERYTHROCYTES EX VIVO

EHA Library, Christian Di Buduo, 385792

EFFECT OF DECITABINE ON MACROPHAGE PHENOTYPE AND FUNCTION IN VITRO IN THE CONTEXT OF AML

EHA Library, Jacobien Hilberink, 385793

THE IMPACT OF CYTOTOXIC THERAPY ON THE RISK OF PROGRESSION AND DEATH IN PATIENTS WITH CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE.

EHA Library, Marissa Li, 385794

H3K36 HISTONE METHYLTRANSFERASE NSD3 FUNCTIONS AS A CRUCIAL EPIGENETIC REGULATOR OF ERYTHROPOIESIS

EHA Library, Arunim Shah, 385795

C3G CONTROLS MEGAKARYOCYTE INFLUENCE ON MYELOID COMMITMENT OF HEMATOPOIETIC STEM CELLS UPON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION.

EHA Library, Óscar Herranz, 385796

EXTRACELLULAR ATP CONTRIBUTES TO ERYTHROPOIESIS-SUPPORTIVE MICROENVIRONMENT UNDER CHRONIC STRESS CONDITIONS

EHA Library, Sanja Momčilović, 385797

M2-LIKE MONOCYTE-DERIVED MACROPHAGES PROTECT AML CELL LINES AND PRIMARY AML CELLS AGAINST THERAPY-INDUCED APOPTOSIS

EHA Library, Katerina Miari, 385798

REAFFIRMING HEMATOPOIETIC PROGENITORS LINEAGE COMMITMENT BY TRANSCRIPTIONAL ATLAS

EHA Library, Yongjian Yue, 385799

BONE MARROW MORPHOLOGY DIAGNOSTIC ENVIRONMENT USING YOLO/RESNET ARTIFICIAL INTELLIGENCE MODEL

EHA Library, Matjaz Sever, 385800

EXPLORING A NOVEL TREATMENT STRATEGY FOR ACQUIRED APLASTIC ANEMIA TARGETING PPAR SIGNALING PATHWAY.

EHA Library, Liping Yang, 385801

CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.

EHA Library, Nawid Albinger, 385802

DELIVERY OF THERAPEUTIC RNA TO THE BONE MARROW IN MULTIPLE MYELOMA USING CD38-TARGETED LIPID NANOPARTICLES

EHA Library, Dana Tarab-Ravski, 385803

CD84-TARGETED CART-CELL THERAPY: A NOVEL STRATEGY FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES

EHA Library, Nela Klein González, 385804

MILESTONE (MODIFYING ELANE GOLDBERG–HOGNES BOX TO INHIBIT EXPRESSION), A UNIVERSAL, SAFE AND EFFECTIVE CRISPR/CAS9N-MEDIATED GENOME EDITING STRATEGY FOR ELANE RELATED SEVERE CONGENITAL NEUTROPENIA

EHA Library, Masoud Nasri, 385805

MINING THE GENOME FOR ERYTHROID SPECIFIC ENHANCERS TO OPTIMIZE GENE THERAPY VECTORS FOR BETA-HEMOGLOBINOPATHIES

EHA Library, Kiriaki Paschoudi, 385806

TUMOR-SPECIFIC, T-CELL-TARGETING MICRORNA IS ASSOCIATED WITH CART CELL FAILURE IN B CELL MALIGNANCIES

EHA Library, Karan Chohan, 385807

CLINICAL TRANSLATION OF A NOVEL, POTENT AND WELL-CHARACTERIZED INDUCED REGULATORY T-CELL PRODUCT AGAINST GRAFT VERSUS HOST DISEASE

EHA Library, Memnon Lysandrou, 385808

SLEEPING BEAUTY PLATFORM FOR ENGINEERING CAR-CIK CELLS TOWARD A MULTI-TARGETING STRATEGY IN B-ALL

EHA Library, Alex Moretti, 385809

DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS

EHA Library, Margaret Duffy, 385810

NOVEL DUAL-TARGETING AND SURFACE-ENGINEERED BIO-ORTHOGONALLY LENTIVIRAL VECTORS FOR IN VIVO CAR-T CELLS GENERATION

EHA Library, Heng Mei, 385811

PHARMACOKINETIC PROFILE OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A), FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T CELL THERAPY FOR PATIENTS WITH RELAPSED / REFRACTORY B CELL MALIGNANCIES (IMAGINE STUDY)

EHA Library, Anil Kamat, 385812

HUMAN CD117 AS AN IMMUNOTHERAPEUTIC TARGET IN PRECLINICAL MODELS OF ADVANCED SYSTEMIC MASTOCYTOSIS

EHA Library, Anne Kaiser, 385813

SAR442257, A CD38/CD28/CD3 TRISPECIFIC ANTIBODY, POTENTIATES CAR T-CELL ACTIVITY AGAINST LARGE B-CELL LYMPHOMA

EHA Library, Patrick Reville, 385814

REFINED PHENOTYPE OF SENESCENT T CELLS UNVEILS HIGH ANTI-TUMOR ACTIVITY DESPITE IMPAIRED PROLIFERATION AND DISTURBED METABOLIC ACTIVITY: NEW IMPLICATIONS FOR CANCER IMMUNOTHERAPY

EHA Library, Kevin Legscha, 385815

NKG2A DELETION IN HUMAN NATURAL KILLER CELLS ENHANCES ANTI-TUMOR RESPONSES AND PROMOTES TUMOR INFILTRATION

EHA Library, Roel Klein Wolterink, 385816

HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY

EHA Library, Hiroko Nishida, 385817

A NOVEL GENE THERAPY VECTOR FOR BETA-HEMOGLOBINOPATHIES WITH A SELECTIVE EXPANSION CASSETTE

EHA Library, ALEXANDRA KIRTSOU, 385818

COMPARISON OF DIFFERENT METHODS FOR GENETIC CORRECTION OF GRISCELLI SYNDROME TYPE II-DERIVED STEM CELLS

EHA Library, Özgür Dogus Erol, 385819

NON-MYELOTOXIC CHEMICALS AS A PREPARATORY REGIMEN FOR HEMATOPOIETIC STEM CELL GENE THERAPY

EHA Library, MEHMET EMİN ŞEKER, 385820

UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS

EHA Library, Martina Fiumara, 385821

RAMAN SPECTROSCOPY STUDIES OF IMMUNE RESPONSE ELEMENTS

EHA Library, Paulina Laskowska, 385822

VENETOCLAX MODULATES TIM-3 EXPRESSION ON CD8 T CELLS IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Darina Ocadlikova, 385823

IDENTIFICATION OF SURFACEOME CHANGES IN CD19 CAR-T THERAPY-RESISTANT LYMPHOMA CELLS

EHA Library, Marta Krawczyk, 385824

TRANSCRIPTOME-WIDE ANALYSIS OF T CELLS DURING EX VIVO EXPANSION AS PER CURRENT CAR T CELL MANUFACTURING PROTOCOL REVEALS SPECIFIC CHANGES IN T CELL SIGNALING AND HOMING

EHA Library, Harish Sudarsanam, 385825

CAR-T CELLS TARGETING CD38 AND LMP1 EXHIBIT ROBUST ANTI-TUMOR ACTIVITY AGAINST NK/T-CELL LYMPHOMA

EHA Library, Manu Juneja, 385826

DEVELOPMENT OF A GENE THERAPY CELL DEATH-INDUCING SYSTEM REGULATED BY MICRORNAS FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Mafalda Duque, 385827

THE COMPOSITION OF INFUSED CD19-CAR-T PRODUCT IMPACTS ON EFFICACY

EHA Library, Eugenio Galli, 385828

DISTINCT CYTOKINE SIGNATURES OF IDECABTAGENE VICLEUCEL COMPARED TO AXICABTAGENE CILEUCEL AND LISOCABTAGENE MARALEUCEL

EHA Library, Abu-Sayeef Mirza, 385829

CIRCULATING CAR-T CELLS MONITORING OF KINETICS AND EXHAUSTION MARKERS AS PREDICTIVE FACTORS IN B-CELL MALIGNANCIES

EHA Library, Belén Sierro Martínez, 385830

STRONG AND SELECTIVE EX VIVO EXPANSION OF ADAPTIVE NKG2C+/CD57+ NK CELLS FROM CMV SEROPOSITIVE DONORS USING DENDRITIC CELLS DERIVED FROM THE LEUKEMIC CELL LINE DCONE AS FEEDER CELLS.

EHA Library, Hester van Zeeburg, 385831

MULTI-EFFECTOR IMMUNE CELL RETARGETING USING A BISPECIFIC SINGLE-CHAIN VARIABLE FRAGMENT LIBRARY IN AGGRESSIVE B CELL LYMPHOMAS

EHA Library, Max Freihammer, 385832

DISTINCT RATES OF ICANS BUT SIMILAR CYTOKINE SIGNATURES BETWEEN TWO CD19-CAR T CELL THERAPIES: LISOCABTAGENE MARALEUCEL AND AXICABTAGENE CILOLEUCEL

EHA Library, Yusuf Rasheed, 385833

USE OF A FOAMY-VIRUS VECTOR SYSTEM TO PRODUCE AN ‘OFF-THE-SHELF’ FCΓ-CR-T CELL PRODUCT FOR THE TREATMENT OF HEMATOLOGICAL AND SOLID TUMOR MALIGNANCIES

EHA Library, Ioanna Lazana, 385834

TREATMENT WITH A LEUKEMIA-DERIVED DENDRITIC CELL VACCINE INDUCES INNATE AND ADAPTIVE IMMUNE RESPONSE CORRELATING WITH  CLINICAL RESPONSE IN AML PATIENTS IN CR1 WITH MEASURABLE RESIDUAL DISEASE

EHA Library, Hester van Zeeburg, 385835

EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE

EHA Library, Sylvain Choquet, 385836

A NOVEL AND SUCCESSFUL CD7-TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL THERAPY FOR REFRACTORY/RELAPSED MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL)

EHA Library, Peihua Lu, 385837

NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN-LABEL GLOBAL PHASE3 STUDY OF TAB-CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (ALLELE)

EHA Library, Daan Dierickx, 385838

VARNIMCABTAGENE AUTOLEUCEL (VAR-CEL) IN RELAPSED / REFRACTORY CD19+ NON-HODGKIN LYMPHOMA

EHA Library, Nuria Martinez-Cibrian, 385839

INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP

EHA Library, Francesca Tucci, 385840

BISPECIFIC CD19/CD37 CAR-T CELLS IN PATIENTS WITH REFRACTORY OR RELAPSED B-CELL LYMPHOMA

EHA Library, Heng Mei, 385841

RITUXIMAB BASED LYMPHODEPLETION MAY INCREASE ENGRAFTMENT AND EFFICACY OF SECOND INFUSIONS OF CART19 CELLS IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Valentín Ortiz-Maldonado, 385842

PENTAVALENT-SPECIFIC T-CELLS POST HAPLO-IDENTICAL TRANSPLANTATION FOR THE TREATMENT OF OPPORTUNISTIC INFECTIONS

EHA Library, Zoi BOUSIOU, 385843

CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO) WITHOUT CYTOPENIAS

EHA Library, Guenther Koehne, 385844

THIRD-PARTY MULTIVIRUS-SPECIFIC T CELLS FOR THE TREATMENT OF REFRACTORY VIRAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Koray Yalcin, 385845